- Home
- NBY vs INM Comparison
NBY vs INM Comparison
Compare NBY & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBY
- INM
- Stock Information
- Founded
- NBY 2000
- INM 1981
- Country
- NBY United States
- INM Canada
- Employees
- NBY N/A
- INM N/A
- Industry
- NBY
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- NBY
- INM Health Care
- Exchange
- NBY Nasdaq
- INM Nasdaq
- Market Cap
- NBY 2.8M
- INM 2.3M
- IPO Year
- NBY 2007
- INM N/A
- Fundamental
- Price
- NBY $0.63
- INM $3.12
- Analyst Decision
- NBY Strong Buy
- INM
- Analyst Count
- NBY 1
- INM 0
- Target Price
- NBY $0.85
- INM N/A
- AVG Volume (30 Days)
- NBY 107.9K
- INM 84.1K
- Earning Date
- NBY 03-25-2025
- INM 02-12-2025
- Dividend Yield
- NBY N/A
- INM N/A
- EPS Growth
- NBY N/A
- INM N/A
- EPS
- NBY N/A
- INM N/A
- Revenue
- NBY $13,844,000.00
- INM $4,832,013.00
- Revenue This Year
- NBY N/A
- INM N/A
- Revenue Next Year
- NBY $11.73
- INM N/A
- P/E Ratio
- NBY N/A
- INM N/A
- Revenue Growth
- NBY 15.40
- INM N/A
- 52 Week Low
- NBY $0.07
- INM $2.42
- 52 Week High
- NBY $6.30
- INM $15.70
- Technical
- Relative Strength Index (RSI)
- NBY 44.89
- INM 37.82
- Support Level
- NBY $0.61
- INM $3.03
- Resistance Level
- NBY $0.71
- INM $3.48
- Average True Range (ATR)
- NBY 0.05
- INM 0.20
- MACD
- NBY -0.01
- INM 0.05
- Stochastic Oscillator
- NBY 27.27
- INM 35.59
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically eyecare and skincare products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease. It has two reportable segments: Eyecare and Wound Care and Skincare.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.